Hema.to
M├╝nchen
About Hema.to
Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $7.7M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: hema.to
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/hema-to-6897 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.